Text Size A A A

Sun Pharma In The News

Tell a Friend Print Home » Media » Sun Pharma In The News

Sun Pharma gets US FDA nod for zoledronic acid

Sun Pharmaceutical Industries Ltd has received approval from the US Food and Drug Administration to manufacture and market generic zoledronic acid injection, according to the regulator's website. Zole­dronic acid injection is the generic version of Novartis International AG's Zometa. Sun Pharmaceutical has received the ap­proval to sell the drug in 4 mg/5 ml strength.